HomeCTOR • NASDAQ
add
Citius Oncology Inc
Previous close
$1.18
Day range
$1.13 - $1.29
Year range
$0.85 - $4.42
Market cap
82.29M USD
Avg Volume
3.87M
P/E ratio
4.75
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.67M | 32.22% |
Net income | -6.81M | -31.33% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -2.16% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 112.00 | — |
Total assets | 84.37M | 76.74% |
Total liabilities | 38.23M | 72.21% |
Total equity | 46.14M | — |
Shares outstanding | 71.55M | — |
Price to book | 1.84 | — |
Return on assets | -24.81% | — |
Return on capital | -49.79% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -6.81M | -31.33% |
Cash from operations | 126.35K | — |
Cash from investing | -5.00M | — |
Cash from financing | 4.87M | — |
Net change in cash | 112.00 | — |
Free cash flow | -7.15M | -478.23% |
About
Founded
2021
Website
